Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Recruiting · NCT06873100 · Registry updated 2025-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis | Cartilage Diseases, Skin and Connective Tissue Diseases, connective tissue disorder, musculoskeletal system disorder, relapsing polychondritis | Recruiting | Phase 1 / Phase 2 | 2025-03-12 | NCT06873100 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Rheumatology and Immunology, Peking University People's Hospital | Beijing | China | 4 |